Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Cash from Investing Activities: 2015-2022

Historic Cash from Investing Activities for Avadel Pharmaceuticals (AVDL) over the last 8 years, with Dec 2022 value amounting to $22.9 million.

  • Avadel Pharmaceuticals' Cash from Investing Activities rose 49.31% to $22.9 million in Q4 2022 from the same period last year, while for Dec 2022 it was $79.7 million, marking a year-over-year increase of 40.00%. This contributed to the annual value of $51.8 million for FY2024, which is 203.37% up from last year.
  • According to the latest figures from Q4 2022, Avadel Pharmaceuticals' Cash from Investing Activities is $22.9 million, which was up 806.30% from $2.5 million recorded in Q3 2022.
  • In the past 5 years, Avadel Pharmaceuticals' Cash from Investing Activities registered a high of $42.3 million during Q1 2022, and its lowest value of -$80.9 million during Q2 2020.
  • Over the past 3 years, Avadel Pharmaceuticals' median Cash from Investing Activities value was $12.2 million (recorded in 2021), while the average stood at $5.6 million.
  • In the last 5 years, Avadel Pharmaceuticals' Cash from Investing Activities spiked by 3,152.17% in 2018 and then slumped by 1,004.18% in 2020.
  • Over the past 5 years, Avadel Pharmaceuticals' Cash from Investing Activities (Quarterly) stood at $16.2 million in 2018, then plummeted by 68.10% to $5.2 million in 2019, then skyrocketed by 40.06% to $7.2 million in 2020, then soared by 111.57% to $15.3 million in 2021, then skyrocketed by 49.31% to $22.9 million in 2022.
  • Its Cash from Investing Activities was $22.9 million in Q4 2022, compared to $2.5 million in Q3 2022 and $12.0 million in Q2 2022.